Antibiotic resistance of retail food and human Campylobacter isolates on the island of Ireland from 2001-2002.

Epidemiology and Infection
K McGillP Whyte

Abstract

The antimicrobial resistance profiles of Campylobacter isolates recovered from a range of retail food samples (n=374) and humans (n=314) to eight antimicrobial compounds were investigated. High levels of resistance in food C. jejuni isolates were observed for ceftiofur (58%), ampicillin (25%) and nalidixic acid (17%) with lower levels observed for streptomycin (7.9%) and chloramphenicol (8.3%). A total of 80% of human C. jejuni isolates were resistant to ceftiofur, while 17% showed resistance to ampicillin and nalidixic acid, 8.6% to streptomycin and 4.1% to chloramphenicol. Resistance to clinically relevant antimicrobials such as erythromycin, ciprofloxacin and tetracycline was 6.7, 12, and 15% respectively for all food isolates and was similar to corresponding resistance prevalences observed for human isolates, where 6.4, 12 and 13% respectively were found to be resistant. Comparisons of C. jejuni isolates in each location showed a high degree of similarity although some regional variations did exist. Comparison of total C. jejuni and C. coli populations showed minor differences, with C. jejuni isolates more resistant to ampicillin and ceftiofur. Multidrug resistance patterns showed some profiles common to human and clinical ...Continue Reading

References

Apr 1, 1982·Journal of Clinical Pathology·F J Bolton, L Robertson
Jul 23, 1998·Journal of Applied Microbiology·H I Atabay, J E Corry
Aug 26, 1998·Journal of Applied Microbiology·K N StanleyK Jones
Mar 19, 1999·Emerging Infectious Diseases·S F AltekruseD L Swerdlow
May 5, 2000·International Journal of Antimicrobial Agents·A E van den Bogaard, E E Stobberingh
Apr 3, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B M Allos
Jul 4, 2001·Veterinary Research·F M Aarestrup, J Engberg
May 2, 2002·Proceedings of the National Academy of Sciences of the United States of America·Marc LipsitchBruce R Levin
Mar 26, 2003·The Journal of Antimicrobial Chemotherapy·S Uzunovic-Kamberovic
May 23, 2003·Antimicrobial Agents and Chemotherapy·Christiane Gaudreau, Huguette Gilbert
Jul 17, 2003·The Journal of Antimicrobial Chemotherapy·A N OzaS D Neill
Nov 19, 2003·International Journal of Food Microbiology·V Frediani-Wolf, R Stephan
Dec 6, 2003·The Journal of Antimicrobial Chemotherapy·John Turnidge
Dec 10, 2003·BMC Public Health·Ursula LedergerberKatharina D C Stärk
Mar 6, 2004·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Alicia D AndersonFrederick J Angulo
May 12, 2004·Diagnostic Microbiology and Infectious Disease·Lyudmila BoyanovaZacharii Krastev
Jun 23, 2004·Emerging Infectious Diseases·Jørgen EngbergVivian Fussing
Aug 21, 2004·The Journal of Infectious Diseases·Jennifer M NelsonFrederick J Angulo

❮ Previous
Next ❯

Citations

Mar 5, 2009·Future Microbiology·Taradon LuangtongkumQijing Zhang
Sep 19, 2017·Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie·Konstantin MechlerThe Tactics Consortium
May 1, 2018·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Marcelo L SignoriniMaría V Zbrun
Aug 17, 2021·BioMed Research International·Md Ashikur RahmanS M Lutful Kabir

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Campylobacteriosis (ASM)

Campylobacteriosis is caused by the bacteria Campylobacter jejuni and is a common cause of gastroenteritis in humans. Discover the latest research on Campylobacteriosis here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.